dehydroepiandrosterone has been researched along with Bladder, Overactive in 1 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matarazzo, MG | 1 |
| Sarpietro, G | 1 |
| Fiorito, D | 1 |
| Di Pasqua, S | 1 |
| Ingrassano, S | 1 |
| Panella, MM | 1 |
| Cianci, A | 1 |
| Caruso, S | 1 |
1 other study available for dehydroepiandrosterone and Bladder, Overactive
| Article | Year |
|---|---|
Intravaginal 6.5 mg prasterone administration in postmenopausal women with overactive bladder syndrome: A pilot study.
Topics: Administration, Intravaginal; Atrophy; Dehydroepiandrosterone; Female; Humans; Pilot Projects; Postm | 2021 |